(Google Translation)
Takeda, on December 5 ask Osaka for extraordinary general meeting Shire
Takeda Pharmaceutical has officially announced that it will hold an extraordinary shareholders' meeting in Osaka that quests for the pros and cons of the acquisition of Ireland's pharmaceutical major Shire. The event date is December 5, and a notice of convocation is sent to nearby shareholders. Shire will also open at extraordinary plenary on the same day (London time), as soon as the acquisition is completed on January 8, 2019. Japan's first gigantic pharmaceutical company (mega · pharma) with sales exceeding 3 trillion yen is born.
In May, Takeda Pharmaceutical will buy less than 7 trillion yen against Shire ...